| Device Classification Name |
Diabetic Retinopathy Detection Device
|
| 510(k) Number |
K221183 |
| Device Name |
AEYE-DS |
| Applicant |
| AEYE Health, Inc. |
| 200 Park Avenue (17th Floor) |
|
New York,
NY
10166
|
|
| Applicant Contact |
Zack Dvey-Aharon |
| Correspondent |
| Hogan Lovells US LLP |
| 555 13th Street NW |
|
Washington,
DC
20004
|
|
| Correspondent Contact |
John Smith |
| Regulation Number | 886.1100 |
| Classification Product Code |
|
| Date Received | 04/25/2022 |
| Decision Date | 11/10/2022 |
| Decision |
Substantially Equivalent
(SESE) |
| Regulation Medical Specialty |
Ophthalmic
|
| 510k Review Panel |
Ophthalmic
|
| Summary |
Summary
|
| Type |
Traditional
|
| Clinical Trials |
NCT04612868
|
| Reviewed by Third Party |
No
|
| Combination Product |
No
|
Predetermined Change Control Plan Authorized |
No
|
|
|